Protai (פרוטאיי ביו בע"מ) Company Profile: Funding, Investors & Partnerships

Protai (פרוטאיי ביו בע"מ)

Protai develops an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered. Protai leverages mass spectrometry-derived proteomics data and other protein-oriented large-scale datasets, building on the latest advances in proteomics and machine learning to enable novel insights on mechanisms of action and disease causality.Protai develops an end-to-end AI-based platform that comprehensively maps the course of disease on t Show More

Alpha Score

50.0

Total Funding$ 20.00 M